e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Obstructive sleep apnoea: clinical aspects II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli?
K. Ozmen Suner, A. N. Annakkaya, U. Toru, T. Dumlu, O. Balbay, P. Arbak, L. Yilmaz Aydin (Duzce, Hakkari, Turkey)
Source:
Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Session:
Obstructive sleep apnoea: clinical aspects II
Session type:
Thematic Poster Session
Number:
3931
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Ozmen Suner, A. N. Annakkaya, U. Toru, T. Dumlu, O. Balbay, P. Arbak, L. Yilmaz Aydin (Duzce, Hakkari, Turkey). Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli?. Eur Respir J 2011; 38: Suppl. 55, 3931
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006
Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 362s
Year: 2005
The impact of obstructive sleep apnea in case of acute coronary syndrome
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020
Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Resistant arterial hypertension and obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Investigation of various factors in obstructive sleep apnea syndrome patients
Source: Eur Respir J 2006; 28: Suppl. 50, 194s
Year: 2006
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
The association of chronic obstructive pulmonary disease and sleep apnea syndrome (overlap syndrome)
Source: Eur Respir J 2002; 20: Suppl. 38, 495s
Year: 2002
Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Obstructive sleep apnea can cause pulmonary hypertension in the absence of lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept